Evaluation of Laparoscopic Non Anatomical Liver Resection in Hepatic Pathology

Launched by ASSIUT UNIVERSITY · Dec 3, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a type of surgery called laparoscopic non-anatomical liver resection, which is a minimally invasive procedure to remove certain liver conditions. Laparoscopy allows surgeons to operate using small tools and tiny incisions instead of making large cuts, which can lead to quicker recovery times, less pain, and shorter hospital stays. The trial aims to evaluate how safe and effective this method is for patients with specific liver issues, such as benign tumors, certain types of cancer that can be removed, and cysts.

To participate in this trial, individuals must be at least 18 years old and have one of the eligible liver conditions mentioned. However, those who are immunocompromised, have certain complications that prevent laparoscopic surgery, or may have difficulty keeping follow-up appointments will not be eligible. Participants can expect to undergo the laparoscopic procedure and will be monitored for their recovery and overall outcomes. This trial is not yet recruiting, but it aims to gather important information that could help improve liver surgery in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * any male or female above 18 that has one of the following pathologies and underwent non anatomical hepatic resection:
• • hepatic benign tumours as adenoma
• • resectable secondary malignancies (2)
• • any type of hepatic cysts e.g., hydatid cyst
• • HCC on top of liver cirrhosis.
• Exclusion Criteria:
• • 1) any immunocompromised patient 2) Patient with contraindicdtions to use laparoscopy. 3) patient who are difficult to follow up.